← Every applicant
Aiping Pharm Inc FDA Approvals
7 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| DOXYCYCLINENew drugOct 1, 2025CAPSULE, ORAL |
| RIVAROXABANNew drugMay 14, 2025TABLET, ORAL |
| PREGABALINNew drugJan 28, 2025TABLET, EXTENDED RELEASE, ORAL |
| ARFORMOTEROL TARTRATENew drugApr 2, 2024SOLUTION, INHALATION |
| CAPTOPRILNew drugJan 27, 2023TABLET, ORAL |
| GUANFACINE HYDROCHLORIDENew drugJun 8, 2022TABLET, ORAL |
| CHOLESTYRAMINENew drugJan 21, 2022POWDER, ORAL |